SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000868278-23-000014
Filing Date
2023-08-11
Accepted
2023-08-11 16:10:43
Documents
63
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q prph-20230630.htm   iXBRL 10-Q 1028135
2 EX-31.1 prph-20230630xexx3111.htm EX-31.1 10907
3 EX-31.2 prph-20230630xexx3121.htm EX-31.2 10757
4 EX-32.1 prph-20230630xexx3211.htm EX-32.1 5239
5 EX-32.2 prph-20230630xexx3221.htm EX-32.2 5089
  Complete submission text file 0000868278-23-000014.txt   6431696

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prph-20230630.xsd EX-101.SCH 46884
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prph-20230630_cal.xml EX-101.CAL 94976
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prph-20230630_def.xml EX-101.DEF 235375
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prph-20230630_lab.xml EX-101.LAB 642239
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prph-20230630_pre.xml EX-101.PRE 394173
57 EXTRACTED XBRL INSTANCE DOCUMENT prph-20230630_htm.xml XML 823137
Mailing Address 711 STEWART AVE, SUITE 200 GARDEN CITY NEW YORK NY 11530
Business Address 711 STEWART AVE, SUITE 200 GARDEN CITY NEW YORK NY 11530 (215) 345-0919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21617 | Film No.: 231164178
SIC: 2834 Pharmaceutical Preparations